Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-05-13T03:35:39.318Z Has data issue: false hasContentIssue false

P01-294 - Depression and Agoraphobia in a Patient with Myasthenia Gravis

Published online by Cambridge University Press:  17 April 2020

E. Pan
Affiliation:
Department of Psychiatry, Istanbul, Turkey
A. Algul
Affiliation:
Department of Psychiatry, Istanbul, Turkey
C. Basoglu
Affiliation:
Department of Psychiatry, Istanbul, Turkey
S. Ebrinc
Affiliation:
Department of Psychiatry, Istanbul, Turkey
M.A. Ates
Affiliation:
Department of Psychiatry, Istanbul, Turkey
U.B. Semiz
Affiliation:
Department of Psychiatry, Istanbul, Turkey
M.G. Senol
Affiliation:
Department of Neurology, GATA Haydarpasha Training Hospital, Istanbul, Turkey
M. Cetin
Affiliation:
Department of Psychiatry, Istanbul, Turkey

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Myasthenia gravis (MG), is a chronic, autoimmune disease involving neuromuscular junctions [1]. Psychopathological disturbances and misdiagnosed as a psychiatric disorder are frequently reported in patients with MG because of variable and fluctuating course of disease [2]. However, during the course of the disease, mainly depression and anxiety disorders can be added to the clinics [1].

Case

The complaints such as weakness, difficulty swallowing and speaking that worsening at evening, may be easily supposed neurotic disorders, in a twenty-two year old male patient, has started about two months ago. In neurology clinic, in requested psychiatric consultation; there were complaints like inability to breathe, sweating, palpitations, reluctance, pessimism and unhappiness.

The patient has diagnosed according to DSM IV-TR as “Agoraphobia without panic disorder” and “Major Depression, Single Episod”. Escitolopram titrated by 20 mg/day has started. Depressive and agoraphobic symptoms have disappeared at the end of four weeks (HAM-A-D:24;11-21;9).

Discussion

MG patients, especially during the beginning of disease symptoms in almost all patients with the appeal was referred to the psychiatric services and 1/3 of it has been reported as psychiatric mis-diagnosis [1,2]. Choice of psychotropic drugs is important that do not affect the respiratory center and neuromuscular transmission. Agents, used in the treatment of MG, can inflame psychopathology and can create resistance to psychotropic treatment. Therefore, cooperation of neurologist and psychiatrist is important.

Type
Consultation liaison psychiatry
Copyright
Copyright © European Psychiatric Association 2010

References

Magni, G., Micaglio, G., Lalli, R., Bejato, L., Cadeago, Mr., Mersky, H., Angelini, C. Psychiatric disturbances associated with myasthenia gravis. Acta Psyc Scand 1988; 77: 443445CrossRefGoogle ScholarPubMed
Santy, P.A. Undiagnosed myasthenia gravis in emergency psychiatric referrals. Ann Emerg Med 1983; 12: 397398Google Scholar
Submit a response

Comments

No Comments have been published for this article.